4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001209191-21-029066
Options or other derivatives
- Chief Medical Officer acquired 35,675 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Dawson Michael John Chief Medical Officer | 2021-04-27 | Grant or award · Stock Option (Right to Buy) | +5,438 | 5,438 | D | ||
| Dawson Michael John Chief Medical Officer | 2021-04-27 | Grant or award · Stock Option (Right to Buy) | +20,391 | 20,391 | D | ||
| Dawson Michael John Chief Medical Officer | 2021-04-27 | Grant or award · Stock Option (Right to Buy) | +5,084 | 5,084 | D | ||
| Dawson Michael John Chief Medical Officer | 2021-04-27 | Grant or award · Stock Option (Right to Buy) | +1,962 | 1,962 | D | ||
| Dawson Michael John Chief Medical Officer | 2021-04-27 | Grant or award · Stock Option (Right to Buy) | +2,800 | 2,800 | D | ||
Loading xslF345X03/doc4.xml…